SciELO - Scientific Electronic Library Online

 
vol.39 issue1Using Doppler flowmetry in the preterm growth restriction managementFunction of Receptor 1 in uptaking transferrin and its relation to iron deficiency and iron gestational preeclampsia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Obstetricia y Ginecología

Print version ISSN 0138-600X

Abstract

VILLEGAS VALVERDE, Carlos Agustín  and  ARANGO PRADO, María del Carmen. Involvement of regulatory T cells in ovarian cancer. Rev Cubana Obstet Ginecol [online]. 2013, vol.39, n.1, pp. 23-32. ISSN 0138-600X.

Regulatory T cells (Treg) lymphocytes are a subpopulation of lymphoid cells whose function is the regulation of the immune system. These cells have suppressor functions involved in the development and monitoring of malignancies. In ovarian cancer, an increase of Treg in tumor microenvironment and systemic circulation has been shown. The objective of this paper is to update the knowledge related to immune system involvement in ovarian cancer. Document review was used, through information search engines available on Hinari. The increase of Treg lymphocytes in the tumor microenvironment and systemic level is one of the mechanisms allowing the tumor to evade the immune response. This mechanism does not have the same impact in all tumors, however, ovarian cancer itself determines the existence of the disease progress. The Treg cells inhibit effector cells by mechanisms dependent on cell-cell contact and the release of cytokines such as interleukin-10 and beta transforming growth factor. The result of this increase is helping to trigger the tolerance mechanisms to the immune system action, thereby associating with poor prognostic parameters. There is scientific evidence on the involvement of Treg lymphocytes in ovarian cancer, which have allowed the understanding the impact they have on this disease clinical features and prognosis, offering attractive new therapeutic targets that will improve this disease course.

Keywords : ovarian cancer; regulatory T cells; immune response; immunotherapy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )